Inspire Medical Systems (INSP) has a profit margin of 14.33%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for INSP is 14.33% as of March 2026. That compares with 7.92% in the prior-year period — up 81.0% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Inspire Medical Systems's historical trend and sector peers before judging valuation or financial health.
Over the past year, INSP's profit margin moved from 7.92% to 14.33% — a 81.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Inspire Medical Systems's valuation or profitability profile.
Against Healthcare companies, INSP currently prints 14.33% for profit margin, while the sector average sits near 15.29%. That is roughly 6.3% below the sector mean. Large gaps often invite a closer look at Inspire Medical Systems's growth, margins, and balance sheet.
Profit Margin shows how effectively Inspire Medical Systems converts resources into returns. At 14.33%, INSP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 7.92% in the prior-year period — up 81.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting INSP's profit margin (14.33%), review year-over-year change from 7.92%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.